We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$15.8B
AUM Growth
+$2.12B
Cap. Flow
+$1.31B
Cap. Flow %
8.28%
Top 10 Hldgs %
13.54%
Holding
1,739
New
469
Increased
384
Reduced
350
Closed
529

Sector Composition

Rank Sector Weight
1 Healthcare 20.82%
2 Technology 17.45%
3 Consumer Discretionary 13.82%
4 Industrials 12.86%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$641B
$316M 2%
2,427,659
+1,964,480
+424% +$260M
META icon
2
Meta Platforms (Facebook)
META
$1.47T
$311M 1.97%
1,817,029
+380,026
+26% +$63.4M
ZTS icon
3
Zoetis
ZTS
$31.7B
$236M 1.49%
3,683,896
+1,134,291
+44% +$71M
QQQ icon
4
PUT
Invesco QQQ Trust
QQQ
$492B
$216M 1.36%
+14,024
New +$2.01M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.25T
$211M 1.34%
4,334,740
+98,620
+2% +$4.68M
AMAT icon
6
Applied Materials
AMAT
$371B
$180M 1.14%
3,470,645
+2,718,958
+362% +$123M
PFE icon
7
Pfizer
PFE
$159B
$177M 1.12%
5,189,813
+731,870
+16% +$23.5M
DHR icon
8
Danaher
DHR
$152B
$169M 1.07%
2,210,350
+610,141
+38% +$45.2M
SPGI icon
9
S&P Global
SPGI
$131B
$165M 1.04%
1,055,075
-117,118
-10% -$17.8M
KEYS icon
10
Keysight
KEYS
$54.7B
$160M 1.01%
3,809,906
-706,592
-16% -$28.9M
SEE
11
DELISTED
Sealed Air
SEE
$139M 0.88%
3,232,501
+722,236
+29% +$32M
PM icon
12
Philip Morris
PM
$298B
$134M 0.85%
1,208,774
+797,505
+194% +$92.8M
CSL icon
13
Carlisle Companies
CSL
$14.1B
$126M 0.8%
1,264,444
+60,920
+5% +$5.9M
ROST icon
14
Ross Stores
ROST
$73.4B
$125M 0.79%
1,925,033
+461,711
+32% +$26.6M
PTC icon
15
PTC
PTC
$17.2B
$124M 0.79%
2,222,293
-168,837
-7% -$9.35M
TFX icon
16
Teleflex
TFX
$5.91B
$123M 0.78%
507,201
-11,261
-2% -$2.45M
STZ icon
17
Constellation Brands
STZ
$22.4B
$121M 0.76%
605,888
+34,741
+6% +$6.88M
AMZN icon
18
Amazon
AMZN
$2.87T
$103M 0.65%
2,136,440
-430,940
-17% -$21.2M
TXN icon
19
Texas Instruments
TXN
$237B
$100M 0.63%
1,111,617
+284,263
+34% +$23.4M
PANW icon
20
Palo Alto Networks
PANW
$301B
$89M 0.56%
3,709,542
+1,886,388
+103% +$43M
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$138B
$86.1M 0.54%
566,179
+145,864
+35% +$22M
BTI icon
22
British American Tobacco
BTI
$121B
$82M 0.52%
1,322,526
+1,235,240
+1,415% +$79.7M
AET
23
DELISTED
Aetna Inc
AET
$81.2M 0.51%
510,821
+73,625
+17% +$11.5M
GSK icon
24
GSK
GSK
$101B
$80.1M 0.51%
1,562,223
+666,630
+74% +$33.8M
BERY
25
DELISTED
Berry Global Group, Inc.
BERY
$79.4M 0.5%
1,516,175
+190,212
+14% +$9.94M

Similar funds

Marshall Wace North America's Q3 2017 Portfolio in Review

As of Q3 2017, Marshall Wace North America held 1,739 positions worth $15.8B, up 16% from $13.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.31B of net new capital in Q3 2017, opening 469 new positions and adding to 384 existing holdings. Its largest new stake was Delta Air Lines: 1,523,510 shares worth $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Terminix Global Holdings, Inc., an estimated $113M trimmed.

  • Marshall Wace North America's largest Q3 2017 buy was Delta Air Lines: 1,523,510 shares worth $73.1M.
  • Marshall Wace North America added most to Johnson & Johnson in Q3 2017, an estimated $260M increase.
  • Marshall Wace North America's biggest Q3 2017 reduction was Terminix Global Holdings, Inc., cutting an estimated $113M.
  • Marshall Wace North America fully exited Reynolds American Inc in Q3 2017, selling an estimated $130M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $15.8B portfolio in Q3 2017.
  • Marshall Wace North America opened 469 new positions and closed 529 in Q3 2017.
  • Marshall Wace North America's portfolio value rose 16% quarter-over-quarter to $15.8B.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.